Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -299,615 | -208,518 | -128,225 | -51,694 | -152,148 |
| Depreciation Amortization | -4,656 | -4,319 | -3,840 | -2,225 | -8,057 |
| Accounts payable and accrued liabilities | 13,910 | 10,285 | 5,492 | 1,597 | -3,453 |
| Other Working Capital | 22,992 | 12,630 | 3,944 | -9,438 | 2,660 |
| Other Operating Activity | 26,265 | 18,812 | 13,425 | 7,354 | 26,319 |
| Operating Cash Flow | $-241,104 | $-171,110 | $-109,204 | $-54,406 | $-134,679 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -630 | -528 | -395 | -187 | -972 |
| Purchase Of Investment | -310,446 | -285,947 | -187,251 | -89,992 | -703,015 |
| Sale Of Investment | 506,162 | 400,897 | 232,307 | 106,246 | 278,958 |
| Other Investing Activity | -800 | -800 | -800 | -750 | 0 |
| Investing Cash Flow | $194,286 | $113,622 | $43,861 | $15,317 | $-425,029 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 306,981 | 2,794 | 1,997 | 1,533 | 645,913 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -13 |
| Other Financing Activity | 1,916 | 19,821 | 19,821 | 0 | -39,227 |
| Financing Cash Flow | $308,897 | $22,615 | $21,818 | $1,533 | $606,673 |
| Beginning Cash Position | 92,646 | 92,646 | 92,646 | 92,646 | 45,681 |
| End Cash Position | 354,725 | 57,773 | 49,121 | 55,090 | 92,646 |
| Net Cash Flow | $262,079 | $-34,873 | $-43,525 | $-37,556 | $46,965 |
| Free Cash Flow | |||||
| Operating Cash Flow | -241,104 | -171,110 | -109,204 | -54,406 | -134,679 |
| Capital Expenditure | -630 | -528 | -395 | -187 | -972 |
| Free Cash Flow | -241,734 | -171,638 | -109,599 | -54,593 | -135,651 |